Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Long-term outcome in survivors of neonatal tetanus following specialist intensive care in Vietnam

Authors: Huynh T. Trieu, Nguyen Thi Kim Anh, Huynh Ngoc Thien Vuong, T. T. M. Dao, Nguyen Thi Xuan Hoa, Vo Ngoc Cat Tuong, Pham Tam Dinh, Bridget Wills, Phan Tu Qui, Le Van Tan, Lam Minh Yen, Saraswathy Sabanathan, Catherine Louise Thwaites

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Neonatal tetanus continues to occur in many resource-limited settings but there are few data regarding long-term neurological outcome from the disease, especially in settings with critical care facilities.

Methods

We assessed long-term outcome following neonatal tetanus in infants treated in a pediatric intensive care unit in southern Vietnam. Neurological and neurodevelopmental testing was performed in 17 survivors of neonatal tetanus and 18 control children from the same communities using tools previously validated in Vietnamese children.

Results

The median age of children assessed was 36 months. Eight neonatal tetanus survivors and 9 community control cases aged < 42 months were tested using the Bayley III Scales of Infant and Toddler Development (Bayley III-VN) and 8 neonatal tetanus survivors and 9 community controls aged ≥42 months were tested using the Movement Assessment Battery for Children. No significant reductions in growth indices or neurodevelopmental scores were shown in survivors of neonatal tetanus compared to controls although there was a trend towards lower scores in neonatal tetanus survivors. Neurological examination was normal in all children except for two neonatal tetanus survivors with perceptive deafness and one child with mild gross motor abnormality. Neonatal tetanus survivors who had expienced severe disease (Ablett grade ≥ 3) had lower total Bayley III-VN scores than those with mild disease (15 (IQR 14–18) vs 24 (IQR 19–27), p = 0.05) with a significantly lower cognitive domain score (3 (IQR 2–6) severe disease vs 7 (IQR 7–8) mild disease, p = 0.02).

Conclusions

Neonatal tetanus is associated with long-term sequelae in those with severe disease. In view of these findings, prevention of neonatal tetanus should remain a priority.
Literature
1.
go back to reference Trieu HT, Lubis IN, Qui PT, Yen LM, Wills B, Thwaites CL, et al. Neonatal tetanus in Vietnam: comprehensive intensive care support improves mortality rates. J Pediatric Infect Dis Soc. 2015;5(2):227–30.CrossRefPubMedPubMedCentral Trieu HT, Lubis IN, Qui PT, Yen LM, Wills B, Thwaites CL, et al. Neonatal tetanus in Vietnam: comprehensive intensive care support improves mortality rates. J Pediatric Infect Dis Soc. 2015;5(2):227–30.CrossRefPubMedPubMedCentral
2.
go back to reference Vandelaer J, Partridge J, Suvedi BK. Process of neonatal tetanus elimination in Nepal. J Public Health. 2009;31(4):561–5.CrossRef Vandelaer J, Partridge J, Suvedi BK. Process of neonatal tetanus elimination in Nepal. J Public Health. 2009;31(4):561–5.CrossRef
3.
go back to reference Jeena PM, Coovadia HM, Gouws E. Risk factors for neonatal tetanus in KwaZulu-Natal. S Afr Med J. 1997;87(1):46–8.PubMed Jeena PM, Coovadia HM, Gouws E. Risk factors for neonatal tetanus in KwaZulu-Natal. S Afr Med J. 1997;87(1):46–8.PubMed
6.
go back to reference Anlar B, Yalaz K, Dizmen R. Long-term prognosis after neonatal tetanus. Dev Med Child Neurol. 1989;31(1):76–80.CrossRefPubMed Anlar B, Yalaz K, Dizmen R. Long-term prognosis after neonatal tetanus. Dev Med Child Neurol. 1989;31(1):76–80.CrossRefPubMed
7.
go back to reference Barlow JL, Mung’Ala-Odera V, Gona J, Newton CR. Brain damage after neonatal tetanus in a rural Kenyan hospital. Trop Med Int Heal. 2001;6(4):305–8.CrossRef Barlow JL, Mung’Ala-Odera V, Gona J, Newton CR. Brain damage after neonatal tetanus in a rural Kenyan hospital. Trop Med Int Heal. 2001;6(4):305–8.CrossRef
8.
go back to reference Barros AJD, Ewerling F. Early childhood development: a new challenge for the SDG era. Lancet Glob Heal. 2016;4(12):e873–4.CrossRef Barros AJD, Ewerling F. Early childhood development: a new challenge for the SDG era. Lancet Glob Heal. 2016;4(12):e873–4.CrossRef
10.
go back to reference Ablett J, Ablett JJL. Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit. In: Symposium on tetanus in Great Britain Leeds: Leeds General Infi rmary; 1967. p. 1–10. Ablett J, Ablett JJL. Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit. In: Symposium on tetanus in Great Britain Leeds: Leeds General Infi rmary; 1967. p. 1–10.
11.
go back to reference Bayley N. Bayley Scales of Infant Development third edition: Technical Manual. Antonio: The Psychological Corporation; 2006. Bayley N. Bayley Scales of Infant Development third edition: Technical Manual. Antonio: The Psychological Corporation; 2006.
12.
go back to reference Watter P. Movement Assessment Battery for Children (Movement ABC). Aust J Physiother. 2006;52(2003):68.PubMed Watter P. Movement Assessment Battery for Children (Movement ABC). Aust J Physiother. 2006;52(2003):68.PubMed
13.
go back to reference Lam PK, Trieu HT, Lubis IND, Loan HT, Thuy TTD, Wills B, et al. Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants. Int J Infect Dis. 2014;33C:7–11. Lam PK, Trieu HT, Lubis IND, Loan HT, Thuy TTD, Wills B, et al. Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants. Int J Infect Dis. 2014;33C:7–11.
14.
go back to reference Cutter R. Auditory nerve involvement after tetanus antitoxin: first reported case. J Am Med Ass. 1936;106:1006–7.CrossRef Cutter R. Auditory nerve involvement after tetanus antitoxin: first reported case. J Am Med Ass. 1936;106:1006–7.CrossRef
15.
go back to reference Berger M, Sachs A. Perceptive deafness associated with prophylactic use of tetanus antitoxin. AMA Arch Otolaryngol. 1953;57:501–8.CrossRefPubMed Berger M, Sachs A. Perceptive deafness associated with prophylactic use of tetanus antitoxin. AMA Arch Otolaryngol. 1953;57:501–8.CrossRefPubMed
16.
go back to reference Skevas A, Kastanioudakis I, Exarchakos G, Assimakopoulos D. Perceptive bilateral deafness following clinical tetanus to a neonate. Int J Pediatr Otorhinolaryngol. 1992;23(2):177–80.CrossRefPubMed Skevas A, Kastanioudakis I, Exarchakos G, Assimakopoulos D. Perceptive bilateral deafness following clinical tetanus to a neonate. Int J Pediatr Otorhinolaryngol. 1992;23(2):177–80.CrossRefPubMed
17.
go back to reference Davis JW, Odd D, Jary S, Luyt K. The impact of a sepsis quality improvement project on neurodisability rates in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. Davis JW, Odd D, Jary S, Luyt K. The impact of a sepsis quality improvement project on neurodisability rates in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed.
18.
go back to reference Alshaikh B, Yee W, Lodha A, Henderson E, Yusuf K, Sauve R. Coagulase-negative staphylococcus sepsis in preterm infants and long-term neurodevelopmental outcome. J Perinatol Nature Publishing Group. 2014;34(2):125–9.CrossRef Alshaikh B, Yee W, Lodha A, Henderson E, Yusuf K, Sauve R. Coagulase-negative staphylococcus sepsis in preterm infants and long-term neurodevelopmental outcome. J Perinatol Nature Publishing Group. 2014;34(2):125–9.CrossRef
Metadata
Title
Long-term outcome in survivors of neonatal tetanus following specialist intensive care in Vietnam
Authors
Huynh T. Trieu
Nguyen Thi Kim Anh
Huynh Ngoc Thien Vuong
T. T. M. Dao
Nguyen Thi Xuan Hoa
Vo Ngoc Cat Tuong
Pham Tam Dinh
Bridget Wills
Phan Tu Qui
Le Van Tan
Lam Minh Yen
Saraswathy Sabanathan
Catherine Louise Thwaites
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2748-3

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.